Predicting placenta accreta risk in pregnant women with placenta previa
Part of Women’s health & pregnancy clinical trials.
This study uses a blood test (hCG-h) to help predict if pregnant women with placenta previa and a previous C-section may have placenta accreta, a condition where the placenta grows too deeply into the uterine wall. The goal is to improve early detection and planning for a safer delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant.
- You have had at least one previous C-section.
- You are in your second or third trimester (between about 13 and 40 weeks of pregnancy).
- You are between 18 and 45 years old.
- You do not have a known chromosomal abnormality (like Down syndrome) in your current pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound scoring system to help predict how severe placenta accreta may be and to plan for safer delivery outcomes. It aims to improve understanding of this condition that can cause heavy bleeding after childbirth.
This study looks at blood tests to predict if the placenta is too attached to the womb in women with placenta previa. The goal is to help plan safer deliveries.
This trial looks at how to diagnose and what happens to pregnant women with a condition where the placenta grows too deeply into the uterus (placental accreta). It may help doctors better understand the condition and improve care.
This trial tests a surgical approach that aims to manage placenta accreta while possibly preserving the uterus. It is for pregnant women who have had a previous cesarean section and are diagnosed with this condition after 28 weeks of pregnancy.
This study looks at how deeply the placenta attaches to the womb in women with a condition called placenta accreta. It aims to better understand the condition to improve care and outcomes.
This study uses ultrasound to measure the placenta and the uterine muscle where it attaches, to help predict heavy bleeding after childbirth in women with placenta accreta. The goal is to better identify who might be at risk, so doctors can be prepared and improve safety during delivery.
Hear when a new Placenta Accreta / Percreta trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.